Lv2
190 积分 2024-08-19 加入
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
15小时前
待确认
Zolbetuximab plus mFOLFOX6 in patients with CLDN18.2-positive, HER2-negative, untreated, locally advanced unresectable or metastatic gastric or gastro-oesophageal junction adenocarcinoma (SPOTLIGHT): a multicentre, randomised, double-blind, phase 3 trial
16小时前
已完结
Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors
15小时前
已采纳
Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors
15小时前
已撤回
Biologically inspired information integration pooling module of spiking neural networks for rolling bearing fault diagnosis
15小时前
待审核
Mim8 Bispecific Antibody Prophylaxis in Hemophilia A with or without Inhibitors
15小时前
已驳回
GTBIM: A GraphSage–transformer-based approach for influence maximization with dynamic layer weighting in multilayer networks
15小时前
已采纳
Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial
15小时前
已采纳
Rationale, Design, and Baseline Clinical Characteristics of the Ziltivekimab Cardiovascular Outcomes Trial
15小时前
已采纳
皖公网安备34019202002308
